صيدلية بيروت - سرت" - تم توفير علاج الأعصاب Seroxat 💊 الشركة الإيرلندية.. موجود لدى صيدلية بيروت🌷 | Facebook
![GlaxoSmithKline 'paid rivals not to sell cheaper copies of its drugs': Lack of competition 'cost NHS £200m' | Daily Mail Online GlaxoSmithKline 'paid rivals not to sell cheaper copies of its drugs': Lack of competition 'cost NHS £200m' | Daily Mail Online](https://i.dailymail.co.uk/i/pix/2013/04/19/article-0-19646FB3000005DC-983_306x324.jpg)
GlaxoSmithKline 'paid rivals not to sell cheaper copies of its drugs': Lack of competition 'cost NHS £200m' | Daily Mail Online
![A box of Seroxat is seen in this illustration picture taken in Bucharest April 19, 2013. Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that A box of Seroxat is seen in this illustration picture taken in Bucharest April 19, 2013. Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that](https://c8.alamy.com/compit/2e5h99p/a-box-of-seroxat-is-seen-in-this-illustration-picture-taken-in-bucharest-april-19-2013-britains-competition-body-accused-glaxosmithkline-of-market-abuse-for-striking-deals-with-three-generic-drugmakers-that-paid-them-to-delay-launching-cheap-copies-of-its-antidepressant-seroxat-gsk-britains-biggest-drugmaker-said-it-believed-it-had-acted-lawfully-if-it-is-found-to-have-broken-the-law-it-could-be-fined-up-to-10-percent-of-its-worldwide-turnover-which-amounted-to-26-4-billion-pounds-40-4-billion-in-2012-the-move-by-the-office-of-fair-trading-oft-is-the-latest-example-of-regulator-2e5h99p.jpg)
A box of Seroxat is seen in this illustration picture taken in Bucharest April 19, 2013. Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that
![A Seroxat box and pills are seen in this illustration picture taken in Bucharest April 19, 2013. Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers A Seroxat box and pills are seen in this illustration picture taken in Bucharest April 19, 2013. Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers](https://c8.alamy.com/compes/2e6bn4e/a-seroxat-box-and-pills-are-seen-in-this-illustration-picture-taken-in-bucharest-april-19-2013-britains-competition-body-accused-glaxosmithkline-of-market-abuse-for-striking-deals-with-three-generic-drugmakers-that-paid-them-to-delay-launching-cheap-copies-of-its-antidepressant-seroxat-gsk-britains-biggest-drugmaker-said-it-believed-it-had-acted-lawfully-if-it-is-found-to-have-broken-the-law-it-could-be-fined-up-to-10-percent-of-its-worldwide-turnover-which-amounted-to-26-4-billion-pounds-40-4-billion-in-2012-the-move-by-the-office-of-fair-trading-oft-is-the-latest-example-of-r-2e6bn4e.jpg)